Related Experiment Video
Updated: Aug 19, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Acquired glucose sensitivity of k-ras transformed fibroblasts
F Chiaradonna1, C Magnani, E Sacco
1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.
Abstract:
Mutational activation of the ras gene is critical for the onset of different malignant phenotypes. We constructed a dominant negative mutant (GEF-DN) of a Ras activator protein (guanine nucleotide-exchange factor) that upon over-expression in k-ras transformed NIH 3T3 fibroblasts strongly reduces intracellular Ras*GTP, reverting these cells to wild-type phenotype for morphology, anchorage-independent growth and reduction of tumour formation in nude mice. Here we review evidence showing that the enhanced proliferation potential of NIH-ras cells requires high initial glucose concentration in the medium and sustained Ras pathway activation. The exquisite sensitivity of NIH-ras fibroblasts to a shortage in nutrient and energy supply highlights an acquired fragility of cancer cells that may be exploited for therapeutic purposes.
Insights
Mutational activation of the ras gene drives cancer. A dominant-negative Ras activator mutant reverted Ras-transformed cells to a wild-type phenotype, revealing cancer cell fragility.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Ras gene mutations are crucial drivers of malignant transformation.
- Ras pathway activation significantly impacts cell proliferation and tumor formation.
Purpose of the Study:
- To investigate the role of Ras pathway activation in cancer cell phenotype.
- To explore the therapeutic potential of targeting Ras activators.
Main Methods:
- Construction of a dominant-negative mutant (GEF-DN) of a Ras activator protein.
- Over-expression of GEF-DN in k-ras transformed NIH 3T3 fibroblasts.
- Assessment of cellular morphology, anchorage-independent growth, and tumor formation in nude mice.
Main Results:
- GEF-DN over-expression reduced intracellular Ras*GTP levels.
- Reversion of transformed NIH 3T3 fibroblasts to a wild-type phenotype.
- Demonstrated dependence of NIH-ras cells on high glucose for proliferation.
- Highlighted acquired metabolic fragility in cancer cells.
Conclusions:
- Targeting Ras activator proteins can revert cancer cell phenotypes.
- Ras-transformed cells exhibit heightened sensitivity to nutrient deprivation.
- This metabolic vulnerability presents a potential therapeutic strategy for Ras-driven cancers.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
cAMP-dependent Protein Kinase Pathways
Insulin: The Receptor and Signaling Pathways

